Efforts for Expedited Process to Get Medical Marijuana Lauded in Nevada
- LEGALITIES, MEDICAL MARIJUANA, NEWS
- June 22, 2016

A new survey from Fort Hays State University’s Docking Institute shows majority support among Kansans for cannabis reform. About 59 percent of adults back legalizing recreational marijuana, while 70 percent favor medical use. Support crosses party lines, with 75 percent of Democrats, 78 percent of independents, and 59 percent of Republicans in favor of medical
READ MORE
A new Florida regulation is sparking controversy after revoking medical marijuana cards from patients convicted of drug-related offenses. According to a recent USA Today report, more than 160 patients have already lost or are in danger of losing access to their prescribed cannabis treatments. The rule, approved under Senate Bill 2514 and signed by Governor
READ MORE
A growing number of older adults are turning to medical cannabis for relief from pain, anxiety, and sleep issues, but experts at Stanford Medicine warn that seniors face heightened risks. Modern cannabis products are far more potent than in past decades, sometimes containing up to 90% THC, increasing the risk of accidental overuse and dangerous
READ MORE
West Virginia legalized medical cannabis in 2017, granting access to more than 35,000 cardholders for the treatment of serious health conditions. The program allows patients — following certification from a registered physician and a $50 application — to purchase up to six ounces of cannabis per month, but only in approved forms like oils, tinctures,
READ MORE
A House Appropriations Committee vote has advanced a spending bill that could halt federal cannabis reform and weaken protections for state medical marijuana programs. The fiscal year 2026 Commerce-Justice-Science bill includes Section 607, which bars the use of federal funds to reschedule or deschedule marijuana. This would effectively stall the Drug Enforcement Administration’s review of
READ MORE
In a landmark regulatory shift, President Donald Trump’s Department of Justice has rescinded dozens of pending and projected rules, dismantling longstanding DEA obstacles to medical cannabis research. The decisive move, announced September 15, strips away the procedural shields that allowed the DEA to delay legitimate marijuana science, notably for FDA-authorized clinical trials targeting Huntington’s disease
READ MORE